Literature DB >> 11669287

Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma.

E R Salter1, D Tichansky, E E Furth, A M Herlyn.   

Abstract

Squamous cell carcinomas (SCCs) are the most common malignancies in man. While clinical specimens are theoretically ideal to study tumor development and progression, practical difficulties such as normal cell contamination, the presence of different cell types. and limited material make preclinical studies of model systems involving a homogeneous population of normal or transformed cells preferable. Tumor-associated antigens (TAAs) found on the cell surface, including integrins, mucins, cadherins, growth factor receptors, membrane bound antigens, and glycoproteins are known to play an important role in squamous carcinogenesis. We hypothesized that (1) alterations in TAA expression in vitro predict in vivo alterations, (2) analysis of a group of TAAs would provide a better indication of SCC tumorigenesis than any single marker, and (3) SCCs with independence from exogenous growth factors in vitro would demonstrate the most aggressive growth in vivo. The cell line which grew best in vitro without serum or other supplements demonstrated the most rapid tumor growth. whereas cell lines which grew only with supplements rarely formed tumors. Normal keratinocytes. eight SCC and two immortal keratinocyte cell lines were evaluated by flow cytometry for the expression of 10 cell surface markers, including alpha and beta integrins, minor blood group-related carbohydrate determinants. carcinoembryonic antigen-related proteins, E-cadherin, and GA733 (epithelial glycoprotein. epithelial cell adhesion molecule). None of the cell lines with abnormal expression of < or = 2 markers formed tumors, whereas all lines with altered expression of > or = 3 markers formed tumors. Using GA733 expression as an example, we found that altered TAA expression in vitro predicted the presence of TAA alterations in clinical specimens. In summary, in vitro independence from supplements for optimal growth and altered expression of > or = 3 cell surface markers were good predictors of SCC tumorigenesis. These findings may be useful in decreasing the need for whole animal tumorigenicity experiments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669287     DOI: 10.1290/1071-2690(2001)037<0530:taaeag>2.0.co;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  31 in total

1.  A comparison of CEA-S and CEA concentrations in sera and the independence of CEA-S, NCA and blood group antigens.

Authors:  T S Edgington; E F Plow; W Go; R Herberman; P Burtin; I Jordan; C Chavkin; D H de Heer; R M Nakamura
Journal:  Bull Cancer       Date:  1976 Oct-Dec       Impact factor: 1.276

Review 2.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  A mucin containing the X, Y, and H type 2 carbohydrate determinants is shed by carcinoma cells.

Authors:  U Rodeck; M Herlyn; K Leander; P Borlinghaus; H Koprowski
Journal:  Hybridoma       Date:  1987-08

4.  Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors.

Authors:  M Brockhaus; J L Magnani; M Herlyn; M Blaszczyk; Z Steplewski; H Koprowski; V Ginsburg
Journal:  Arch Biochem Biophys       Date:  1982-09       Impact factor: 4.013

Review 5.  The biology of the 17-1A antigen (Ep-CAM).

Authors:  M Balzar; M J Winter; C J de Boer; S V Litvinov
Journal:  J Mol Med (Berl)       Date:  1999-10       Impact factor: 4.599

6.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

7.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

8.  Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.

Authors:  J Fagerberg; A L Hjelm; P Ragnhammar; J E Frödin; H Wigzell; H Mellstedt
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

9.  Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.

Authors:  D L Hudson; P M Speight; F M Watt
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

10.  Efficient selection of human tumor growth-inhibiting monoclonal antibodies.

Authors:  D Herlyn; M Herlyn; A H Ross; C Ernst; B Atkinson; H Koprowski
Journal:  J Immunol Methods       Date:  1984-10-12       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.